|
AU2015200383A1
|
|
Monitoring health and disease status using clonotype profiles
|
|
WO2015058159A1
|
|
Predicting patient responsiveness to immune checkpoint inhibitors
|
|
WO2015013461A2
|
|
Cancer vaccination with antigen evolution
|
|
US2014234835A1
|
|
Rare clonotypes and uses thereof
|
|
US2015299800A1
|
|
Monitoring mantle cell lymphoma clonotypes in peripheral blood after immunotransplant
|
|
WO2014062945A1
|
|
Monitoring clonotypes of plasma cell proliferative disorders in peripheral blood
|
|
WO2014062959A1
|
|
Monitoring diffuse large b-cell lymphoma from peripheral blood samples
|
|
US2016115532A1
|
|
High sensitivity mutation detection using sequence tags
|
|
CA2875542A1
|
|
Method of sequence determination using sequence tags
|
|
WO2013181428A2
|
|
Predicting relapse of chronic lymphocytic leukemia patients treated by allogeneic stem cell transplantation
|
|
WO2013158936A1
|
|
Monitoring immunoglobulin heavy chain evolution in b-cell acute lymphoblastic leukemia
|
|
US2013302801A1
|
|
Detection and quantification of sample contamination in immune repertoire analysis
|
|
CN104395481A
|
|
Detection and quantitation of sample contamination in immune repertoire analysis
|
|
US2015038346A1
|
|
Monitoring immune responsiveness to cancer vaccination
|
|
WO2013134302A1
|
|
Monitoring immune responsiveness to cancer vaccination
|
|
EP2794925A2
|
|
Monitoring transformation of follicular lymphoma to diffuse large b-cell lymphoma by immune repertoire analysis
|
|
WO2013090390A2
|
|
Method of measuring immune activation
|
|
EP2788507A1
|
|
Method of measuring immune activation
|
|
US2014336059A1
|
|
Clonotypes as biometric specimen tags
|
|
WO2013055595A1
|
|
Determining responsiveness of autoimmune patients to dmard treatment
|
